GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by cognitive decline, brain atrophy due to neuronal and synapse loss, and formation of two pathological lesions: extracellular amyloid plaques, composed largely of amyloid-beta peptide (Aβ), and neurofibrillary tangles formed by intracellular aggregates of hyperphosphorylated tau protein. Lesions mainly accumulate in brain regions that modulate cognitive functions such as the hippocampus, septum or amygdala. These brain structures have dense reciprocal glutamatergic, cholinergic, and GABAergic connections and their relationships directly affect learning and memory processes, so they have been proposed as highly susceptible regions to suffer damage by Aβ during AD course. Last findings support the emerging concept that soluble Aβ peptides, inducing an initial stage of synaptic dysfunction which probably starts 20-30 years before the clinical onset of AD, can perturb the excitatory-inhibitory balance of neural circuitries. In turn, neurotransmission imbalance will result in altered network activity that might be responsible of cognitive deficits in AD. Therefore, Aβ interactions on neurotransmission systems in memory-related brain regions such as amygdaloid complex, medial septum or hippocampus are critical in cognitive functions and appear as a pivotal target for drug design to improve learning and dysfunctions that manifest with age. Since treatments based on glutamatergic and cholinergic pharmacology in AD have shown limited success, therapies combining modulators of different neurotransmission systems including recent findings regarding the GABAergic system, emerge as a more useful tool for the treatment, and overall prevention, of this dementia. In this review, focused on inhibitory systems, we will analyze pharmacological strategies to compensate neurotransmission imbalance that might be considered as potential therapeutic interventions in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Theta oscillations in the hippocampus
Buzsáki, G. (2002) · Neuron · doi:10.1016/s0896-6273(02)00586-x · Cited by 3,332
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Tripartite synapses: glia, the unacknowledged partner
Araque, A., Parpura, V., Sanzgiri, R. P., & Haydon, P. G. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01349-6 · Cited by 2,529 · cited 1×
“The term “tripartite synapse” was proposed in order to describe this cellular configuration which involves presynaptic neuron, postsynaptic neuron, and astrocytes (Araque et al., 1999; Perea et al., 2009).”
BackgroundInherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434 · cited 1×
“In most cases, this alteration results in its aggregation and accumulation in tissues as fibrillar deposits that finally induce neuronal death (Bucciantini et al., 2002).”
BackgroundTripartite synapses: astrocytes process and control synaptic information
Perea, G., Navarrete, M., & Araque, A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.05.001 · Cited by 1,820 · cited 2×
“Recent reports support the new concept that cognitive function arises from a cooperative activity between both neurons and glia (Perea et al., 2009; Fields et al., 2014).”
BackgroundAlzheimer Mechanisms and Therapeutic Strategies
Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758 · cited 2×
“…(Farlow, 2009; McKeage, 2009), so that strategies aimed to reestablish the balance between both systems, particularly in early stages of the disease, seem to be the most appropriate to act on the functional deficits caused by Aβ (Huang and Mucke, 2012; Mucke and Selkoe, 2012; Verret et al., 2012).”
BackgroundSynchronization of cortical activity and its putative role in information processing and learning
Singer, W. (1993) · Annual Review of Physiology · doi:10.1146/annurev.ph.55.030193.002025 · Cited by 1,685
Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653 · cited 6×
“Damages found in septum and hippocampus could explain those cognitive deficits (Moreno et al., 2007; Palop et al., 2007; Villette et al., 2010; Rubio et al., 2012).”
BackgroundInfluentialAmyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651
Unfolding the role of protein misfolding in neurodegenerative diseases
Soto, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1007 · Cited by 1,506
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477
Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329 · cited 1×
“Some of these proposals include a cascade of reactions that could involve the blockade of the glutamate recruitment by microglia (Hickman et al., 2008), alteration of the glutamatergic neurotransmission (Ashenafi et al., 2005; Santos-Torres et al., 2007), or modification of both glutamate…”
BackgroundGABA-containing neurons in the septum control inhibitory interneurons in the hippocampus
Freund, T. F., & Antal, M. (1988) · Nature · doi:10.1038/336170a0 · Cited by 1,283
Astrocytic Purinergic Signaling Coordinates Synaptic Networks
Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H., Moss, S. J., McCarthy, K., & Haydon, P. G. (2005) · Science · doi:10.1126/science.1116916 · Cited by 1,280 · cited 1×
“Several gliotransmitters released from astrocytes modulate synaptic plasticity in those brain structures (Yang et al., 2003; Pascual et al., 2005; Panatier et al., 2006) and participate in learning and memory processes.”
BackgroundAmunts, K., Kedo, O., Kindler, M., Pieperhoff, P., Mohlberg, H., Shah, N. J., Habel, U., Schneider, F., & Zilles, K. (2005) · Anatomy and Embryology · doi:10.1007/s00429-005-0025-5 · Cited by 1,264 · cited 1×
“Based on the amygdala’s cytoarchitecture its subnuclei can be classified in superficial amygdaloid nuclei, centromedial group, and the basolateral complex (Heimer et al., 1999; Amunts et al., 2005).”
BackgroundVerret, L., Mann, E. O., Hang, G. B., Barth, A. M. I., Cobos, I., Ho, K., Devidze, N., Masliah, E., Kreitzer, A. C., Mody, I., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.046 · Cited by 1,216
Bak, L. K., Schousboe, A., & Waagepetersen, H. S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03913.x · Cited by 1,114
The human amygdala and the emotional evaluation of sensory stimuli
Zald, D. H. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00248-5 · Cited by 1,062
Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
Mucke, L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006338 · Cited by 1,000 · cited 4×
“…(Farlow, 2009; McKeage, 2009), so that strategies aimed to reestablish the balance between both systems, particularly in early stages of the disease, seem to be the most appropriate to act on the functional deficits caused by Aβ (Huang and Mucke, 2012; Mucke and Selkoe, 2012; Verret et al., 2012).”
BackgroundInfluentialDefined types of cortical interneurone structure space and spike timing in the hippocampus
Somogyi, P., & Klausberger, T. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.078915 · Cited by 927
The tripartite synapse: roles for gliotransmission in health and disease
Halassa, M. M., Fellin, T., & Haydon, P. G. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.12.005 · Cited by 852
Epilepsy and Cognitive Impairments in Alzheimer Disease
Palop, J. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.15 · Cited by 684 · cited 3×
“…in the mechanisms that lead to excessive neural excitability and epilepsy that can be observed in hAPP transgenic mice model (Palop et al., 2007; Palop and Mucke, 2009, 2010a,b; Mucke and Selkoe, 2012), this type of potassium channels emerge as an interesting potential target to be studied,…”
BackgroundSanchez, P. E., Zhu, L., Verret, L., Vossel, K. A., Orr, A. G., Cirrito, J. R., Devidze, N., Ho, K., Yu, G.-Q., Palop, J. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121081109 · Cited by 638
Lüscher, C., & Slesinger, P. A. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2834 · Cited by 617 · cited 1×
“Numerous studies have emphasized its role in several pathological processes in the central nervous system such as epilepsy, pain, addiction, Parkinson or Down syndrome (Luscher and Slesinger, 2010).”
BackgroundAβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss
Talantova, M., Sanz-Blasco, S., Zhang, X., Xia, P., Akhtar, M. W., Okamoto, S.-I., Dziewczapolski, G., Nakamura, T., Cao, G., Pratt, A. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306832110 · Cited by 600
Um, J. W., Kaufman, A. C., Kostylev, M., Heiss, J. K., Stagi, M., Takahashi, H., Kerrisk, M. E., Vortmeyer, A., Wisniewski, T., Koleske, A. J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.036 · Cited by 572
Contribution of astrocytes to hippocampal long-term potentiation through release of d -serine
Yang, Y., Ge, W., Chen, Y., Zhang, Z., Shen, W., Wu, C., Poo, M., & Duan, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2431073100 · Cited by 533
Bland, B. H., & Oddie, S. D. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00358-8 · Cited by 520
Hasselmo, M. E. (2005) · Hippocampus · doi:10.1002/hipo.20116 · Cited by 502 · cited 1×
“Because theta and gamma activity play a functional role in memory formation and retrieval (Bastiaansen and Hagoort, 2003; Hasselmo, 2005; Lisman, 2005), disruption of septohippocampal projection might explain cognitive deterioration in neurodegenerative diseases.”
BackgroundThe molecular bases of Alzheimer’s disease and other neurodegenerative disorders
Maccioni, R. B., Muñoz, J. P., & Barbeito, L. (2001) · Archives of Medical Research · doi:10.1016/s0188-4409(01)00316-2 · Cited by 474 · cited 1×
“Oxidative stress and inflammatory response induced by astrocytes and microglia activation may have a dual role in pathophysiology of AD with neuroprotective and detrimental consequences (Maccioni et al., 2001; Schipper et al., 2006).”
BackgroundLisman, J. (2005) · Hippocampus · doi:10.1002/hipo.20121 · Cited by 435 · cited 1×
“Because theta and gamma activity play a functional role in memory formation and retrieval (Bastiaansen and Hagoort, 2003; Hasselmo, 2005; Lisman, 2005), disruption of septohippocampal projection might explain cognitive deterioration in neurodegenerative diseases.”
BackgroundCasas, C., Sergeant, N., Itier, J.-M., Blanchard, V., Wirths, O., van der Kolk, N., Vingtdeux, V., van de Steeg, E., Ret, G., Canton, T., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63388-3 · Cited by 400
Sago, H., Carlson, E. J., Smith, D. J., Kilbridge, J., Rubin, E. M., Mobley, W. C., Epstein, C. J., & Huang, T.-T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6256 · Cited by 382 · cited 1×
“Moreover, mutations in GIRK2 subunit reduced LTP and increased LTD in hippocampus (Sago et al., 1998; Siarey et al., 1999; Wickman et al., 2000) and it is especially relevant in Down syndrome, where cerebral Aβ accumulation is greatly accelerated and leads to invariant early onset AD neuropathology…”
BackgroundNorepinephrine triggers release of glial ATP to increase postsynaptic efficacy
Gordon, G. R. J., Baimoukhametova, D. V., Hewitt, S. A., Rajapaksha, W. R. A. K. J. S., Fisher, T. E., & Bains, J. S. (2005) · Nature Neuroscience · doi:10.1038/nn1498 · Cited by 374
Aisen, P. S., Gauthier, S., Ferris, S. H., Saumier, D., Haine, D., Garceau, D., Duong, A., Suhy, J., Oh, J., Lau, W. C., et al. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.20612 · Cited by 295
Li, G., Bien-Ly, N., Andrews-Zwilling, Y., Xu, Q., Bernardo, A., Ring, K., Halabisky, B., Deng, C., Mahley, R. W., & Huang, Y. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.10.015 · Cited by 288
The role of G protein-coupled receptors in the pathology of Alzheimer's disease
Thathiah, A., & De Strooper, B. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2977 · Cited by 288 · cited 1×
“In fact, Aβ has been shown to disrupt G protein-coupled receptors function (Thathiah and De, 2011), and compromise coupling of the receptor with G protein (Janickova et al., 2013) as well as several different secondary messenger systems (Thathiah and De, 2009; Yang et al., 2011; Fu et al., 2012;…”
BackgroundCSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings
Seppälä, T. T., Nerg, O., Koivisto, A. M., Rummukainen, J., Puli, L., Zetterberg, H., Pyykkö, O. T., Helisalmi, S., Alafuzoff, I., Hiltunen, M., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182563bd0 · Cited by 236
Alzheimer disease and Down syndrome: factors in pathogenesis
Lott, I. T., & Head, E. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.005 · Cited by 212
Sun, B., Halabisky, B., Zhou, Y., Palop, J. J., Yu, G., Mucke, L., & Gan, L. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.10.003 · Cited by 205
Transgenic Mouse Model of Tau Pathology in Astrocytes Leading to Nervous System Degeneration
Forman, M. S., Lal, D., Zhang, B., Dabir, D. V., Swanson, E., Lee, V. M.-Y., & Trojanowski, J. Q. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0081-05.2005 · Cited by 198 · cited 1×
“…may underline several brain disorders (i.e., depression, schizophrenia, and epilepsy; Rajkowska et al., 1999; Cohen-Gadol et al., 2004; Fellin et al., 2004; Webster et al., 2005), as well as specific neurodegenerative diseases (i.e., parkinsonism; Forman et al., 2005; Halassa et al., 2007).”
BackgroundLanctôt, K. L., Herrmann, N., Mazzotta, P., Khan, L. R., & Ingber, N. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900705 · Cited by 191 · cited 3×
“Cerebrospinal GABA studies as well as neuroimaging and postmortem studies have been useful to show the relationship between GABA system and AD (Jimenez-Jimenez et al., 1998; Yew et al., 1999; Lanctot et al., 2004).”
BackgroundMethodIncreased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome
Siarey, R. J., Carlson, E. J., Epstein, C. J., Balbo, A., Rapoport, S. I., & Galdzicki, Z. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00083-0 · Cited by 184 · cited 1×
“Moreover, mutations in GIRK2 subunit reduced LTP and increased LTD in hippocampus (Sago et al., 1998; Siarey et al., 1999; Wickman et al., 2000) and it is especially relevant in Down syndrome, where cerebral Aβ accumulation is greatly accelerated and leads to invariant early onset AD neuropathology…”
BackgroundDrug development for Alzheimer's disease: where are we now and where are we headed?
Sabbagh, M. N. (2009) · The American journal of geriatric pharmacotherapy · doi:10.1016/j.amjopharm.2009.06.003 · Cited by 147
Alzheimer's disease amyloid β-protein and synaptic function
Ondrejcak, T., Klyubin, I., Hu, N.-W., Barry, A. E., Cullen, W. K., & Rowan, M. J. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8091-0 · Cited by 146 · cited 1×
“…shows that soluble forms of Aβ can interfere with hippocampal synaptic plasticity responsible for learning and memory processing, inhibit long-term potentiation (LTP), and enhance long-term depression (LTD; Chen et al., 2000; Freir et al., 2001; Shankar et al., 2008; Ondrejcak et al., 2010).”
BackgroundAltered synapses and gliotransmission in Alzheimer's disease and AD model mice
Mitew, S., Kirkcaldie, M. T. K., Dickson, T. C., & Vickers, J. C. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.010 · Cited by 138 · cited 1×
“GABAergic synapses are preserved in human AD and APP/PS1 transgenic mice (Mitew et al., 2013).”
BackgroundCarlsen, J. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902730407 · Cited by 133 · cited 1×
“GABAergic afferents originating from amygdaloid interneurons of the basolateral complex which synapse on pyramidal cells probably modulate its function (McDonald, 1985; Carlsen, 1988; Carlsen and Heimer, 1988; McDonald and Augustine, 1993).”
BackgroundThe human basal forebrain. Part II
Heimer, L., de Olmos, J. S., Alheid, G. F., Pearson, J., Sakamoto, N., Shinoda, K., Marksteiner, J., & Switzer, R. C. (1999) · Handbook of Chemical Neuroanatomy · doi:10.1016/s0924-8196(99)80024-4 · Cited by 125
Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer’s disease
Takahashi, H., Brasnjevic, I., Rutten, B. P. F., Van Der Kolk, N., Perl, D. P., Bouras, C., Steinbusch, H. W. M., Schmitz, C., Hof, P. R., & Dickstein, D. L. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0242-4 · Cited by 124
Facilitation of glutamatergic neurotransmission by presynaptic nicotinic acetylcholine receptors
Girod, R., Barazangi, N., McGehee, D., & Role, L. W. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00145-3 · Cited by 122
Pathological Substrates of Cognitive Decline in Alzheimer’s Disease
Giannakopoulos, P., Kövari, E., Gold, G., von Gunten, A., Hof, P. R., & Bouras, C. (2009) · Frontiers of Neurology and Neuroscience · doi:10.1159/000197881 · Cited by 101 · cited 1×
“…in basal forebrain and hippocampus, respectively, are particularly vulnerable to Aβ neurotoxic effects (Coyle et al., 1983; Emre et al., 1992; Danysz et al., 2000; Giannakopoulos et al., 2009) while GABAergic neurons are relatively resistant to neurodegeneration in AD (Rissman et al., 2007).”
BackgroundRubio, S. E., Vega‐Flores, G., Martínez, A., Bosch, C., Pérez‐Mediavilla, A., Río, J. D., Gruart, A., Delgado‐García, J. M., Soriano, E., & Pascual, M. (2012) · The FASEB Journal · doi:10.1096/fj.12-208413 · Cited by 98
Baglietto-Vargas, D., Moreno-Gonzalez, I., Sanchez-Varo, R., Jimenez, S., Trujillo-Estrada, L., Sanchez-Mejias, E., Torres, M., Romero-Acebal, M., Ruano, D., Vizuete, M., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100066 · Cited by 98 · cited 1×
“Finally, several studies have reported specific GABAergic interneurons decrease (parvalbumin, calretinin, and somatostatin/NPY immunoreactive neurons) in the hippocampus of the APP/PS1 mice (Ramos et al., 2006; Baglietto-Vargas et al., 2010; Takahashi et al., 2010).”
BackgroundXu, X., An, L., Mi, X., & Zhang, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077796 · Cited by 49 · cited 1×
“Cortical and hippocampal function depends on optimum levels of inhibition (Borhegyi et al., 2004; Kaifosh et al., 2013; Xu et al., 2013; Bissonette et al., 2014) to Frontiers in Cellular Neuroscience www.frontiersin.org June 2014 | Volume 8 | Article 167 | 5 maintain an adequate synaptic plasticity…”
BackgroundA new neuronal target for beta-amyloid peptide in the rat hippocampus
Villette, V., Poindessous-Jazat, F., Bellessort, B., Roullot, E., Peterschmitt, Y., Epelbaum, J., Stéphan, A., & Dutar, P. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.11.024 · Cited by 37 · cited 1×
“Recently, it has been reported in vivo that Aβ injection in dorsal hippocampus induces a selective death of GABAergic neuronal subpopulations projecting to the medial septum (Villette et al., 2012).”
BackgroundModulation of normal and altered hippocampal excitability states by septal networks
Colom, L. V., & Garrido‐Sanabria, E. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21276 · Cited by 17 · cited 1×
“The function of septal neurons of the basal forebrain is to modulate hippocampus and neocortex circuits’ activity in order to maintain sensory information and memory processes (Colom, 2006; Colom and Garrido-Sanabria, 2007).”
Background
Cited by
González-Reyes, R. E., Nava-Mesa, M. O., Vargas-Sánchez, K., Ariza-Salamanca, D., & Mora-Muñoz, L. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00427 · Cited by 527
Self-citationJeremic, D., Jiménez-Díaz, L., & Navarro-López, J. D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101496 · Cited by 306
Self-citationApolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
Najm, R., Jones, E. A., & Huang, Y. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0324-6 · Cited by 183
Infectious agents and Alzheimer's disease
Piekut, T., Hurła, M., Banaszek, N., Szejn, P., Dorszewska, J., Kozubski, W., & Prendecki, M. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2102073 · Cited by 123
Jeremic, D., Sanchez-Rodriguez, I., Jimenez-Diaz, L., & Navarro-Lopez, J. D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107808 · Cited by 89
Metadata
- Authors
- Nava-Mesa, M. O., Jiménez-DÃaz, L., Yajeya, J., & Navarro-Lopez, J. D.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2014-06-25
- Volume
- 8
- Pages
- 167-167
- ISSN
- 1662-5102 (ISSN-L)
- OpenAlex
- W2004378479
- Cited by
- 106
- References
- 58
- FWCI
- 6.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.